Focus on coronavirus disease 2019 associated coagulopathy  

作　　者：Xiang-Hong Yang Ran-Ran Li Ren-Hua Sun Jiao Liu De-Chang Chen 

机构地区：[1]Department of Critical Care Medicine,Zhejiang Provincial People’s Hospital(People’s Hospital of Hangzhou Medical College),Hangzhou,Zhejiang 310014,China [2]Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China [3]Department of Critical Care Medicine,Ruijin North Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 201800,China

出　　处：《Chinese Medical Journal》2020年第18期2239-2241,共3页中华医学杂志（英文版）

摘　　要：The coronavirus disease 2019(COVID-19)has caused a global outbreak and became a major public health issue globally.It has been found that COVID-19 patients are commonly complicated with coagulation abnormities,which are closely associated with the severity and prognosis of patients.A thorough understanding of the prevalence of coagulopathy and potential causes of abnormities of coagulation parameters in COVID-19 patients is crucial for clinicians to standardize the diagnosis and management of COVID-19 associated coagulopathy.

关 键 词：DIAGNOSIS patients PROGNOSIS 

分 类 号：R552[医药卫生—血液循环系统疾病] R37[医药卫生—内科学]